Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $21.8 Million - $26 Million
-378,400 Reduced 46.29%
439,000 $30.1 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $18.6 Million - $22.1 Million
381,800 Added 87.65%
817,400 $47.3 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $5.95 Million - $6.54 Million
-119,700 Reduced 21.56%
435,600 $23.6 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $6.82 Million - $7.56 Million
151,200 Added 37.42%
555,300 $27.8 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $2.41 Million - $2.88 Million
60,900 Added 17.74%
404,100 $18.7 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $484,572 - $1.45 Million
13,200 Added 4.0%
343,200 $13.3 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $108B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.